Skip to main content

Ezose Sciences, Kyowa Hakko Ink Glycomics Pact

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it has signed an agreement to collaborate with Kyowa Hakko Kirin on glycomics studies using Ezose's GlycanMap platform.

Under terms of the deal, Kyowa Hakko Kirin will provide funding for several glycan biomarker efforts and other discovery projects, said Pine Brook, NJ-based Ezose. Financial and other terms of the collaboration were not disclosed.

Ezose's GlycanMap platform combines MALDI-TOF mass spectrometry with bioinformatics to structurally identify and quantitate glycans present in complex biological samples. The glycans can be used in developing therapeutics or diagnostics, including companion diagnostics, said Ezose.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.